BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38725185)

  • 21. Continuous Glucose Monitoring and Time in Range: Association with Adverse Outcomes among People with Type 2 or Gestational Diabetes Mellitus.
    Bitar G; Cornthwaite JA; Sadek S; Ghorayeb T; Daye N; Nazeer S; Ghafir D; Cornthwaite J; Chauhan SP; Sibai BM; Fishel Bartal M
    Am J Perinatol; 2024 May; 41(S 01):e1370-e1377. PubMed ID: 36858069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Continuous Glucose Monitoring in Pregnant Women With Diabetes: Distinct Temporal Patterns of Glucose Associated With Large-for-Gestational-Age Infants.
    Law GR; Ellison GT; Secher AL; Damm P; Mathiesen ER; Temple R; Murphy HR; Scott EM
    Diabetes Care; 2015 Jul; 38(7):1319-25. PubMed ID: 25906785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes.
    McLean A; Barr E; Tabuai G; Murphy HR; Maple-Brown L
    Diabetes Technol Ther; 2023 Dec; 25(12):836-844. PubMed ID: 37902969
    [No Abstract]   [Full Text] [Related]  

  • 24. Determinants of preeclampsia in women with type 1 diabetes.
    Gutaj P; Zawiejska A; Mantaj U; Wender-Ożegowska E
    Acta Diabetol; 2017 Dec; 54(12):1115-1121. PubMed ID: 28975446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus.
    Tiselko AV; Kapustin RV; Milyutina YP; Borovik NV; Abashova EI; Yarmolinskaya MI
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9639-9646. PubMed ID: 35264056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009613. PubMed ID: 24782359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
    Polsky S; Garcetti R; Pyle L; Joshee P; Demmitt JK; Snell-Bergeon JK
    PLoS One; 2020; 15(4):e0230476. PubMed ID: 32298269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous Glucose Monitoring in Women with Normal OGTT in Pregnancy.
    Tartaglione L; di Stasio E; Sirico A; Di Leo M; Caputo S; Rizzi A; Caneschi A; De Carolis S; Pitocco D; Lanzone A
    J Diabetes Res; 2021; 2021():9987646. PubMed ID: 34476261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose variability in diabetic pregnancy.
    Dalfrà MG; Sartore G; Di Cianni G; Mello G; Lencioni C; Ottanelli S; Sposato J; Valgimigli F; Scuffi C; Scalese M; Lapolla A
    Diabetes Technol Ther; 2011 Aug; 13(8):853-9. PubMed ID: 21751862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
    Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
    Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.
    Benhalima K; Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C
    Lancet Diabetes Endocrinol; 2024 Jun; 12(6):390-403. PubMed ID: 38697182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
    Murphy HR
    Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.
    Voormolen DN; DeVries JH; Sanson RME; Heringa MP; de Valk HW; Kok M; van Loon AJ; Hoogenberg K; Bekedam DJ; Brouwer TCB; Porath M; Erdtsieck RJ; NijBijvank B; Kip H; van der Heijden OWH; Elving LD; Hermsen BB; Potter van Loon BJ; Rijnders RJP; Jansen HJ; Langenveld J; Akerboom BMC; Kiewiet RM; Naaktgeboren CA; Mol BWJ; Franx A; Evers IM
    Diabetes Obes Metab; 2018 Aug; 20(8):1894-1902. PubMed ID: 29603547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between hyperglycemia in middle and late pregnancy and maternal-fetal outcomes: a retrospective study.
    Gui J; Li A; Su X; Feng L
    BMC Pregnancy Childbirth; 2014 Jan; 14():34. PubMed ID: 24438028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.
    Cohen AL; Wenger JB; James-Todd T; Lamparello BM; Halprin E; Serdy S; Fan S; Horowitz GL; Lim KH; Rana S; Takoudes TC; Wyckoff JA; Thadhani R; Karumanchi SA; Brown FM
    Hypertens Pregnancy; 2014 Feb; 33(1):81-92. PubMed ID: 24354578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
    Sanusi AA; Xue Y; McIlwraith C; Howard H; Brocato BE; Casey B; Szychowski JM; Battarbee AN
    Diabetes Care; 2024 Jan; 47(1):89-96. PubMed ID: 37782847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.